The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, alleging the drugmaker failed to report potential side effects in patients who ...

The FDA this month issued a warning letter to ImmunityBio regarding promotional statements about cancer drug Anktiva that the agency claims are “false or misleading.” The missive marks the first ...

Please provide your email address to receive an email when new articles are posted on . The FDA found “serious violations” of postmarketing adverse drug experience regulations at Novo Nordisk in 2025.

In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after drugmakers for marketing glucagon-like peptide-1 (GLP-1) receptor agonists and ...

As demand for GLP-1 weight loss drugs skyrockets, so does the risk of getting scammed. What we've been seeing in our scam tracker is advertisements about supplements that work just as well as *** ...